Patrick Kelly: Inside the Generic Supply Chain Squeeze
In this episode of the Vital Health Podcast, host Duane Schulthess speaks with Patrick Kelly, Chief Advocacy Officer at the Healthcare Distribution Alliance, to discuss why generic markets face razor-thin margins and concentration risk, what is driving recent drug shortages, how tariffs and reshoring could affect costs, potential ripple effects from Most Favored Nation pricing, and the rise of direct-to-consumer pathways and traceability across the supply chain.
Key Topics:
Generic Market Pressures: Race-to-the-bottom pricing, manufacturer exits, concentration risks.
Shortage Drivers…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.